Date |
Company |
Amount |
Funding type |
Investors |
Therapeutic area |
Type of Information |
2017-07-17 |
Paion (Germany) |
€ 8 million |
private placement |
two undisclosed U.S. institutional investors |
CNS diseases |
Private placement |
2017-07-07 |
Biophytis (France) |
€ 18,7 million |
capital increase - private placement |
Bracknor Investment Group (Dubai) |
Ageing diseases - Muscle disorders - Ophtalmological diseases |
Capital increase |
2017-07-06 |
Evotec (Germany) |
|
grant |
Hamburgische Investitions- und Förderbank (IFB Hamburg) (Germany) |
Cancer - Oncology |
Grant |
2017-07-06 |
Zealand Pharma (Denmark) |
|
capital increase |
|
|
Capital increase |
2017-07-05 |
Anaeropharma Science (Japan) |
$13.2 million |
financing round |
Novartis (Switzerland) Shinsei Corporate Investment (Japan) Seventure Partners (France) Innovation Network Corporation of Japan (Japan) Mitsubishi UFJ Capital (Japan) |
Cancer - Oncology - Cardiovascular diseases |
Financing round |
2017-07-03 |
Sensorion (France) |
up to €25 million |
financing round |
Yorkville Advisors Global (USA) |
Otorhinolaryngology |
Financing round |
2017-06-29 |
Melinta Therapeutics (USA - CT) |
$ 90 million |
loan |
Oberland Capital (USA - NY) |
Infectious diseases |
Loan |
2017-06-27 |
Daytwo (Israel) |
$12 million |
series A financing round |
Seventure Partners (France), J&J (USA - NJ) historical investors |
|
Series A financing round |
2017-06-27 |
LogicBio Therapeutics (USA - MA) |
$ 50 million |
series B financing round |
Arix Bioscience (UK) OrbiMed (USA - NY) Edmond de Rothschild Investment Partners (France) Pontifax (Israel) SBI Japan-Israel Innovation Fundalso (Israel - Japan) |
Rare diseases - Genetic diseases - Infectious diseases |
Series B financing round |
2017-06-26 |
Sangamo Therapeutics (USA - CA) |
$83.4 million |
private placement |
|
Rare diseases - Genetic diseases |
Private placement |
2017-06-26 |
BerGenBio (Norway) |
NOK 24 million ($2.85m) |
grant |
Innovasjon Norge (Norway) |
Cancer - Oncology |
Grant |
2017-06-23 |
Gensight Biologics (France) |
€22.5 million |
capital increase |
|
Rare diseases - Genetic diseases - Ophtalmological diseases |
Capital increase |
2017-06-21 |
Clovis Oncology (USA - CO) |
$300 million |
private placement |
|
Cancer - Oncology |
Private placement |
2017-06-20 |
iOnctura (Switzerland) |
|
financing round |
Merck Ventures (Germany) |
Cancer - Oncology |
Financing round |
2017-06-20 |
Loxo Oncology (USA - CA) |
$260.8 million |
private placement |
|
Cancer - Oncology |
Private placement |
2017-06-20 |
Onxeo (France) |
€15 Million |
private placement |
|
Cancer - Oncology - Rare diseases |
Private placement |
2017-06-14 |
Medixci (UK - Switzerland) |
$300 million |
financing round |
Novartis (Switzerland) Verily, an Alphabet company (USA - CA) European Investment Fund (EIF) (EU) institutional LPs |
|
Financing round |
2017-06-12 |
Abivax (France) |
€390,000 |
loan |
Bpifrance (France) Région Occitanie /Pyrénées-Méditerranée (France) |
Infectious diseases |
Loan |
2017-06-09 |
Idorsia (Switzerland) |
|
IPO |
Johnson&Johnson (J&J) (USA - NJ) |
Cardiovascular diseases - CNS diseases - Immune diseases - Rare diseases |
IPO |
2017-06-08 |
VBL Therapeutics (Israel) |
$2.5 Million |
grant |
Israel Innovation Authority (Israel) formerly known as the Office of the Chief Scientist (OCS) |
Cancer - Oncology |
Grant |